Pred-455 Better (UPDATED)

In clinical trials, PRED-455 has been evaluated in several studies, including a phase II trial in patients with GAD and a phase I trial in healthy volunteers. The results of these studies indicate that PRED-455 is well-tolerated and produces significant anxiolytic effects, as measured by standardized rating scales, such as the Hamilton Anxiety Rating Scale (HAM-A).

: It ensures gloves have adequate strength (force at break) to protect both patients and healthcare workers from cross-contamination [9]. PRED-455